Most patients in clinical response or remission with IL-23 inhibitor icotrokinra at 76 wee ...

A study presented at ACG reveals low dermatology and cervical cancer screening rates in patients with ulcerative colitis and ...

Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a novel composite outcome defined by ...

By Nancy Lapid Oct 15 (Reuters) - Hello Health Rounds readers! Today we highlight a study that found benefits of wearable glucose monitoring devices for all patients with diabetes, regardless of ...

Researchers at Georgia State University identified two metabolite-inspired compounds that showed enhanced anti-inflammatory ...

In the fiercely competitive inflammatory bowel disease (IBD) market, Eli Lilly is making the case for its antibody Omvoh as a ...

Eli Lilly (NYSE: LLY) reported new clinical analyses showing its Omvoh therapy achieved corticosteroid free disease control ...

ABIVAX's obefazimod showed 51% clinical remission vs. 10% placebo in 44-week UC trial, claiming largest phase 3 ...

New data show favorable outcomes with subcutaneous infliximab following intravenous infliximab interruption, regardless of prior antibody status, in adult patients with moderate to severely active ...

A Turkish study finds that cytomegalovirus DNA in colon tissue is associated with severe disease activity and corticosteroid ...

Last year, before I was diagnosed with ulcerative colitis.I started going to the bathroom about 10 times a day.The abdominal ...